Our Children With Type 1 Diabetes: Causes, Solutions, and a New Prognosis

In this post, Carla Atherton, Director of the Healthy Family Formula, relates how she discovered that functional medicine has better answers for why her daughter developed type 1 diabetes.

What Are We Missing in Conventional Care for Type 1 Diabetes?

When I got the call from the doctor that fateful day, (February 2nd, 2012, to be exact), our lives changed forever. “Carla,” she said, “your daughter has diabetes.” I stood in my friend’s entrance with my silver flip phone in my hand while my three children bustled around me getting their boots and jackets on to go home. But we weren’t going home. We were going to the hospital.

When we arrived in the hospital, we trusted the staff to tell us what to do, but it didn’t take long before I realized that our goals and theirs were much different, that they had no answers for us, only a “hush, darling, don’t ask too much,” in response to my questions which later escalated to demands.

Seven years later, I have finally learned all that I should have been taught then, all that I should have been taught all my life, really. The true answers to: “what happened?” and “why?” and “where do we go from here?”

What Causes Type 1 Diabetes?

My goals were not to limp my daughter along with disempowering complacency, short-sighted, impotent goals, and substandard care and not to head to the hospital whenever things hit critical mass. They were to find out what caused my daughter’s illness and then to help her to recover from it in every way: mind, spirit, and body. Instinctually, I knew that there was more to this health thing than what I had ever been taught.

And then I found functional medicine. The science and research, the upgraded and integrative health paradigm together matched what my mama instinct, my scientist brain, my poet heart all knew was right: there was more, much more, for her.

As a mother seven years into this journey with my own daughter AND as a family health professional, I can tell you that much about what we are taught about type 1 diabetes through conventional medicine is only part of the story, and in some cases, it’s not even the story at all.

I discovered that there are many factors that all play significant roles in the onset and perpetuation of type 1 diabetes:

  • Functional assessments
  • Environmental causal factors
  • Infections causal factors
  • Lifestyle factors
  • The connection to the central nervous system

And they all hold keys to the vault of wellness battened down with many heavy chains.

A Functional, Holistic Approach to Type 1 Diabetes

When we don’t take a functional, holistic approach, we miss the opportunity to open up an entire world of possibilities. Did you know that:

  • Intestinal permeability is one of the triad of causal factors for autoimmunity?
  • Many children who have type 1 diabetes also have celiac disease, many of whom are undiagnosed?
  • Type 1 diabetes can be linked to:
    • Hemochromatosis (a typically genetic condition in which excess iron is not eliminated from the body)
    • Toxicity/injury from routine medical childhood procedures
    • A sensitivity to milk (specifically the peptide casein A1-b)

There ARE causes for the onset of type 1 diabetes (not just bad luck), and type 1 can be prevented for our other children.

The Role of the Central Nervous System

The central nervous system plays an integral role in the onset and perpetuation of type 1 diabetes. In type 1 diabetes, the body doesn’t produce insulin, and this allows blood sugar levels to reach dangerously high levels. Therapies that calm the central nervous system such as craniosacral therapy, photobiomodulation, aromatherapy, and acupressure can significantly reduce blood sugar levels.

On the flip side, emotional stressors and environmental stressors such as WiFi can significantly increase blood sugar levels. Controlling blood sugar is not just a numbers game, but contingent on a myriad of chemical, hormonal, nutritional, viral, emotional, environmental, and bacterial factors.

How to Get Off the Blood Sugar Rollercoaster

My concern is this: what are parents like me not being taught about diet, exercise, rest, environment, causes, solutions, treatments, recovery, and future health outcomes? Parents are more than ready to get off of the emotional and physical rollercoaster of chronic illness and to help their children take charge of their health so they can get on with the business of living.

In this series of articles, I will tell you all I know about NOT simply managing type 1 diabetes but transcending the diagnosis. As a holistic family health consultant and mother of a daughter with type 1 diabetes, I have a lot to share with you about a new way to view type 1 diabetes and how to help your children:

  • Stabilize blood sugar
  • Feel better and more healthy on a daily basis
  • Minimize or eliminate hospital visits and emergencies
  • Prevent co-morbitidities and further health complications

You can and should be empowered to create your own child’s healing plan so your family can move beyond the diagnosis.

To read Carla’s series of articles about causes, solutions, and a new prognosis for your child with type 1 diabetes, check out her article about it here.

About Carla Atherton MA FDN-P

Carla Atherton, MA, FDN-P, Family Health Coach, is the director of The Healthy Family Formula, host of The Children’s and Teen Health Summit, author of Family Health Revolution, editor, book junkie and research geek.  She is the insatiably curious mother of three grown (son age 20), almost grown (daughter age 18), and growing (daughter age 15) children, one of whom has type 1 diabetes.

Carla lives on an acreage in rural Saskatchewan, Canada, where she works from a home office with families from all over the world on the reversal of children’s chronic health conditions. Carla is on a revolutionary mission to empower families to transcend our new normal of ill health and chronic disease. You can find out more about her and her work at her website https://healthyfamilyformula.com/

Carla Atherton

Still Looking for Answers?

Visit the Epidemic Answers Practitioner Directory to find a practitioner near you.

Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.

Sources & References

Accurso, A., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008 Apr 8:5:9.

Adebayo, O., et al. The changing face of diabetes in America. Emerg Med Clin North Am. 2014;32(2):319-27.

Bahr, L.S., et al. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study. Trials. 2020 Jan 2;21(1):3.

Banerjee, S., et al. Ayurveda in changing scenario of diabetes management for developing safe and effective treatment choices for the future. J Complement Integr Med. 2015.

Bernstein, R.K. Blood glucose self-monitoring by diabetic patients: refinements of procedural technique. Diabetes Care. 1979 Mar-Apr;2(2):233-6.

Bernstein, R.K. Virtually continuous euglycemia for 5 yr in a labile juvenile-onset diabetic patient under noninvasive closed-loop control. Diabetes Care. 1980 Jan-Feb;3(1):140-3.

Bradford, B.L., et al. Mitochondrial Dysfunction and Type 2 Diabetes. Science. 2005 Jan 21;307(5708):384-7.

Brenton, J.N., et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):637-644.

Brenton, J.N., et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 12;6(4):e565.

Choquet, H., et al. Genomic insights into early-onset obesity. Genome Med. 2010;2(6):36.

Classen, J.B. Review of evidence that epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome are polar opposite responses to iatrogenic inflammation. Curr Diabetes Rev. 2012;8(6):413-8.

Dietch, D.M., et al. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open. 2023 Apr 17;9(3):e70.

Feinman, R.K., et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015 Jan;31(1):1-13.

Hinzmann, R., et al. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665-81.

Laron, Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7.

Karkafi, R.E., et al. Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders. Adv Exp Med Biol. 2023:1411:537-554.

Laron, Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7.

Lennerz, B.S., et al. Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.
Pediatrics. 2018 Jun;141(6):e20173349.

Power, R.A., et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007 Apr;50(4):824-32.

Rector, R.S., et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol. 2010 May;52(5):727-36.

Rosa, J.S., et al. Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes. 2011;12(5):464-72.

Smith, J., et al. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behav Brain Res. 2016 May 1:304:67-70.

Vaarala, O. Is the origin of type 1 diabetes in the gut? Immunol Cell Biol. 2012;90(3):271-6.

Vaarala, O. Gut microbiota and type 1 diabetes. Rev Diabet Stud. 2012;9(4):251-9.

Yuan, J., et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.